Drug Topics
SEPTEMBER 26, 2023
Pharmacists at nearly 2 dozen CVS pharmacy locations called out sick Thursday and Friday to protest recent corporate decisions they say put patients at risk of serious harm.
Pharmacy Times
SEPTEMBER 26, 2023
Tune in to this episode of the Independent Rx Forum to gain a comprehensive understanding of the enduring significance of independent and community pharmacies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
SEPTEMBER 26, 2023
The latest rollout of Covid-19 vaccines has been messy, with people facing more challenges getting one of the updated shots than they may have experienced since the frantic start of the very first vaccination campaign in late 2020 and the first half of 2021. The issues have come as a surprise to people whose appointments have been canceled for lack of vaccine doses, who couldn’t get an appointment at their nearest pharmacy, or who learned with dismay that the place where they got previous
Pharmacy Times
SEPTEMBER 26, 2023
Functional exercise resulted in more improvements for individuals with PCC compared to standard treatment, although individuals must be monitored for adverse events.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
SEPTEMBER 26, 2023
Jobs in health care are known to be challenging for workers’ mental health. But the mental health toll can be especially burdensome for registered nurses, health technicians, and health care support workers, who are at a higher risk of suicide compared to the general population, according to a study published on Tuesday in the Journal of the American Medical Association that looked at a nationally representative cohort of about 1.84 million employed people (both within the health care fie
Pharmacy Times
SEPTEMBER 26, 2023
This disease can, at the very least, help researchers to “identify” the floodgates to definitive tests and therapies for complex psychological and neurological diseases, expert says.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Healthcare
SEPTEMBER 26, 2023
Virgin Pulse and benefits administrator HealthComp are set to merge in a $3 billion deal that aims to drive lower costs and improve outcomes for employers. | Virgin Pulse and benefits administrator HealthComp are set to merge in a $3 billion deal that aims to drive lower costs and improve outcomes for employers.
STAT
SEPTEMBER 26, 2023
WASHINGTON — Almond milk — not almond beverage, almond drink, or even almond juice — appears here to stay. There’s few issues in the food world that generate as much vitriol as the debate over what to call nut, oat, and other plant-based alternatives to cow’s milk.
Drug Topics
SEPTEMBER 26, 2023
A new study in the New England Journal of Medicine found no significant difference in the number of children who received a T1D diagnosis between those with and without a SARS-CoV-2 infection.
STAT
SEPTEMBER 26, 2023
Patriarchy isn’t a word that Ophira Ginsburg expected to be at the center of her work as a cancer researcher but, like an infection, it was invading her everyday work as a medical oncologist. There were times when she saw people treat women’s lives and health with cruel indifference. There were times when she saw women who struggled to access care because of violence or social obligations or stigma.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
SEPTEMBER 26, 2023
Most patients had improved clinical response within 90 days of receiving the dendritic cell vaccine and ASCT.
STAT
SEPTEMBER 26, 2023
The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid. “They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital.
Fierce Pharma
SEPTEMBER 26, 2023
Amid a global expansion spree at WuXi Biologics, the company's immunization-focused subsidiary has christened its inaugural CDMO site in China. | WuXi Vaccines launched its first standalone vaccine contract manufacturing facility in Suzhou. With the plant, the company adds drug substance and drug product capacity for projects in various stages of development.
STAT
SEPTEMBER 26, 2023
Results released Tuesday from an early study of an autoimmune disease drug from Roivant Sciences’ Immunovant showed the treatment could reduce the levels of a key immune marker in the blood, a promising signal. The results are only from a Phase 1 trial, but were anticipated because they were the first-in-human outcomes being reported for the antibody drug, IMVT-1402.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Pharma
SEPTEMBER 26, 2023
As if the talc product liability lawsuits weren’t enough headache for Johnson & Johnson, the New Jersey pharma is now facing another lawsuit from patients, this time about a recent data breach. | As if the talc product liability lawsuits weren’t enough headache for Johnson & Johnson, the New Jersey pharma is now facing another lawsuit from patients, this time about a recent data breach.
STAT
SEPTEMBER 26, 2023
Biosimilars are no longer a new and untested class of medicines. Today, they provide critical treatment options across multiple therapeutic areas. Since the Biologics Price Competition and Innovation Act of 2009 created a regulatory pathway for biosimilar medicine review in the U.S., 37 biosimilars have come to market offering the potential to increase patient choice and cost savings.
Pharmacy Times
SEPTEMBER 26, 2023
In clinical trials, lecanemab showed a reduction of amyloid beta plaque in patients with Alzheimer disease.
Fierce Pharma
SEPTEMBER 26, 2023
As coronavirus concerns increase with the changing of the seasons, the most commonly used oral antiviral treatments are in the spotlight once again. | As coronavirus concerns increase with the changing of the seasons, the most commonly used oral antiviral treatments are in the spotlight once again.
Fierce Healthcare
SEPTEMBER 26, 2023
Expect premiums, benefits and plan choices for Medicare Advantage (MA) and the Medicare Part D prescription drug program to look similar in 2024, the Centers for Medicare & Medicaid Services (C | CMS announced that nearly three-quarters of MA plan beneficiaries will not see their premiums rise.
Fierce Pharma
SEPTEMBER 26, 2023
On a €1 billion quest to build a global mRNA network, Merck KGaA’s MilliporeSigma has rounded out its service offerings to include all key stages of mRNA development, manufacturing and commercializ | On a €1 billion quest to build a global mRNA network, Merck KGaA’s MilliporeSigma has rounded out its service offerings to include all key stages of mRNA development, manufacturing and commercialization.
STAT
SEPTEMBER 26, 2023
Intercept Pharmaceuticals, a firm whose treatment for a prevalent liver disease once made it the hottest stock in biotech, said Tuesday it would sell the company for less than $1 billion. Alfasigma, an Italian pharmaceutical firm, will pay $19 a share for Intercept , in a roughly $800 million cash deal that represents an 80% premium to the company’s recent trading price.
Fierce Healthcare
SEPTEMBER 26, 2023
Digital health company Waltz Health is cracking into the payer market by inking its first partnership. | Digital health company Waltz Health is cracking into the payer market by inking its first partnership.
STAT
SEPTEMBER 26, 2023
Ionis Pharmaceuticals, a California biotech that has spearheaded the development of RNA-targeting medicines, announced on Tuesday that its drug against familial chylomicronemia syndrome, a rare and serious disease that prevents the body from breaking down fats, succeeded in a late-stage clinical trial. The Phase 3 trial, dubbed Balance, enrolled 66 adults who were randomly divided into three groups and given a monthly injection of placebo or one of two doses of olezarsen, the company’s ex
Fierce Pharma
SEPTEMBER 26, 2023
It’s been an uphill battle for Intercept Pharmaceuticals in the three years since the FDA first nixed its attempt to bring Ocaliva to patients with nonalcoholic steatohepatitis (NASH)-related liver | The company inked the buyout at $19 per share after two FDA rejections for Ocaliva in nonalcoholic steatohepatitis-related liver fibrosis and a recent attempt at cutting costs.
Drug Topics
SEPTEMBER 26, 2023
A significantly decreased risk of endometrial cancer was reported among participants with a history of pregnancy compared to those nulliparous.
Fierce Healthcare
SEPTEMBER 26, 2023
Tech-enabled primary care company Cano Health is selling off its senior-focused clinics to Humana's CenterWell in Texas and Nevada, according to an announcement. | Tech-enabled primary care company Cano Health is selling off its senior-focused clinics to Humana's CenterWell in Texas and Nevada, according to an announcement.
The Checkup by Singlecare
SEPTEMBER 26, 2023
You’ve probably heard fruit referred to as “nature’s candy,” thanks to its innate sweetness—but blueberries are almost like nature’s candy and nature’s medicine all in one tiny blue package. Not only are the antioxidant powerhouses packed with vitamins and minerals, but their high fiber content can also make them a heart- and gut-friendly addition to your diet.
Hospital Pharmacy Europe
SEPTEMBER 26, 2023
Environmental sustainability within pharmacy is the subject of a new policy statement published by the International Pharmaceutical Federation (FIP) as it calls for action on climate change. The statement emphasises that as pharmacy practice and medicines cause greenhouse gas emissions and pollution, they both contribute to climate change and ecological damage and thus threaten human health.
Drug Store News
SEPTEMBER 26, 2023
Walmart is now introducing Walmart Discovered, a Roblox activation designed to streamline the discovery of virtual items and creators on the metaverse platform.
Hospital Pharmacy Europe
SEPTEMBER 26, 2023
The Professional Standards Authority (PSA) has escalated concerns to the UK Government over the time it is taking the General Pharmaceutical Council (GPhC) to deal with fitness to practise cases (FtP). While the healthcare super-regulator recognised the GPhC had made some improvements around its handling of FtP cases, it said it had serious concerns over the timeliness of its investigations.
Fierce Healthcare
SEPTEMBER 26, 2023
Elevance Health and Blue Cross and Blue Shield of Louisiana are pressing pause on $2.5 billion merger plans as state regulators raise concerns about the impact it could have on local competition.
Fierce Pharma
SEPTEMBER 26, 2023
Even after Gilead Sciences and Teva Pharmaceutical Industries prevailed in a high- | The preliminary settlement deal comes after Gilead and Teva, a generics giant, prevailed in a high-stakes jury trial this summer.
PharmaVoice
SEPTEMBER 26, 2023
From COTA’s large datasets and AI model assistants to a company guiding patients through cancer care, AI can help — but it’s a long way from human-free.
Pharmacy Times
SEPTEMBER 26, 2023
Researchers find correlation of increased anaphylaxis with the use of a-tryptase.
Expert insights. Personalized for you.
247 
Let's personalize your content